JP2008527031A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008527031A5 JP2008527031A5 JP2007551735A JP2007551735A JP2008527031A5 JP 2008527031 A5 JP2008527031 A5 JP 2008527031A5 JP 2007551735 A JP2007551735 A JP 2007551735A JP 2007551735 A JP2007551735 A JP 2007551735A JP 2008527031 A5 JP2008527031 A5 JP 2008527031A5
- Authority
- JP
- Japan
- Prior art keywords
- synthase
- leukotriene
- activating protein
- family members
- lipoxygenase activating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000004023 5-Lipoxygenase-Activating Proteins Human genes 0.000 claims description 3
- 108090000411 5-Lipoxygenase-Activating Proteins Proteins 0.000 claims description 3
- GWNVDXQDILPJIG-NXOLIXFESA-N leukotriene C4 Chemical compound CCCCC\C=C/C\C=C/C=C/C=C/[C@H]([C@@H](O)CCCC(O)=O)SC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O GWNVDXQDILPJIG-NXOLIXFESA-N 0.000 claims description 3
- 102000042256 MAPEG family Human genes 0.000 claims 2
- 108091077604 MAPEG family Proteins 0.000 claims 2
- 102100033076 Prostaglandin E synthase Human genes 0.000 claims 2
- 101710096361 Prostaglandin E synthase Proteins 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 description 3
- 230000000694 effects Effects 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64455605P | 2005-01-19 | 2005-01-19 | |
| US64452605P | 2005-01-19 | 2005-01-19 | |
| US64455505P | 2005-01-19 | 2005-01-19 | |
| US64455705P | 2005-01-19 | 2005-01-19 | |
| PCT/GB2006/000168 WO2006077401A1 (en) | 2005-01-19 | 2006-01-19 | Pyrrolopyridines useful in the treatment of inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008527031A JP2008527031A (ja) | 2008-07-24 |
| JP2008527031A5 true JP2008527031A5 (cg-RX-API-DMAC7.html) | 2009-04-02 |
Family
ID=36029030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007551735A Withdrawn JP2008527031A (ja) | 2005-01-19 | 2006-01-19 | 炎症の治療に有用なピロロピリジン誘導体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20090048285A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1841766A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2008527031A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2594621A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006077401A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006077366A1 (en) * | 2005-01-19 | 2006-07-27 | Biolipox Ab | Indoles useful in the treatment of inflammation |
| WO2006077367A1 (en) * | 2005-01-19 | 2006-07-27 | Biolipox Ab | Indoles useful in the treatment of inflamation |
| TW200823215A (en) | 2006-08-04 | 2008-06-01 | Merz Pharma Gmbh & Amp Co Kgaa | Pyrazolopyrimidines, a process for their preparation and the use as a medicine |
| US20100004301A1 (en) * | 2006-12-14 | 2010-01-07 | Benjamin Pelcman | Benzoxazoles Useful in the Treatment of Inflammation |
| EP2303881A2 (en) | 2008-07-14 | 2011-04-06 | Gilead Sciences, Inc. | Fused heterocyclyc inhibitors of histone deacetylase and/or cyclin-dependent kinases |
| JP5640005B2 (ja) | 2008-07-14 | 2014-12-10 | ギリアード サイエンシーズ， インコーポレイテッド | Ｈｄａｃおよび／またはｃｄｋ阻害剤としてのイミダゾシルピリジン化合物 |
| EP2303841A1 (en) | 2008-07-14 | 2011-04-06 | Gilead Sciences, Inc. | Oxindolyl inhibitor compounds |
| KR20110038159A (ko) | 2008-07-28 | 2011-04-13 | 길리애드 사이언시즈, 인코포레이티드 | 사이클로알킬리덴 및 헤테로사이클로알킬리덴 히스톤 데아세틸라아제 억제제 화합물 |
| WO2010076566A2 (en) | 2008-12-30 | 2010-07-08 | Biolipox Ab | Indoles useful in the treatment of inflammation |
| CA2763786C (en) | 2009-06-08 | 2014-09-30 | Gilead Sciences, Inc. | Alkanoylamino benzamide aniline hdac inihibitor compounds |
| ES2463826T3 (es) | 2009-06-08 | 2014-05-29 | Gilead Sciences, Inc. | Compuestos inhibidores de HDAC de cicloalquilcarbamato benzamida anilina |
| GB201006846D0 (en) | 2010-04-23 | 2010-06-09 | Glaxo Group Ltd | Novel compounds |
| TW201204733A (en) | 2010-06-25 | 2012-02-01 | Kowa Co | Novel condensed pyridine or condensed pyrimidine derivative, and medicinal agent comprising same |
| JP5902293B2 (ja) | 2011-04-25 | 2016-04-13 | アッシャー・サード・イニシアティブ・インコーポレイテッド | ピラゾロピリダジンおよび網膜変性疾患およびアッシャー症候群に伴う聴覚損失を治療するための方法 |
| US9227976B2 (en) | 2012-10-25 | 2016-01-05 | Usher Iii Initiative, Inc. | Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome |
| CA2889572C (en) * | 2012-11-08 | 2019-03-05 | Pfizer Inc. | Heteroaromatic compounds as dopamine d1 ligands |
| WO2015088564A1 (en) * | 2013-12-13 | 2015-06-18 | Sunovion Pharmaceuticals Inc. | P2x4 receptor modulating compounds |
| WO2015088565A1 (en) * | 2013-12-13 | 2015-06-18 | Sunovion Pharmaceuticals Inc. | P2x4 receptor modulating compounds and methods of use thereof |
| CA2978823C (en) | 2014-12-29 | 2023-10-10 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Small molecule inhibitors of lactate dehydrogenase and methods of use thereof |
| JOP20190024A1 (ar) | 2016-08-26 | 2019-02-19 | Gilead Sciences Inc | مركبات بيروليزين بها استبدال واستخداماتها |
| JP7050165B2 (ja) | 2018-02-26 | 2022-04-07 | ギリアード サイエンシーズ， インコーポレイテッド | Ｈｂｖ複製阻害剤としての置換ピロリジン化合物 |
| JP7677983B2 (ja) | 2020-01-23 | 2025-05-15 | マイオフォルテ セラピューティクス，インク． | Ｐｇｄｈ阻害剤、およびその作製と使用の方法 |
| EP4178580B1 (en) | 2020-07-09 | 2025-11-05 | Usher III Initiative, Inc. | Bf 844 for use in the treatment of cancer |
| EP4228650A4 (en) * | 2020-10-15 | 2024-12-18 | Myoforte Therapeutics Inc. | INHALATED FORMULATIONS OF PGDH INHIBITORS AND METHODS OF USE THEREOF |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5081138A (en) * | 1986-12-17 | 1992-01-14 | Merck Frosst Canada, Inc. | 3-hetero-substituted-n-benzyl-indoles and prevention of leucotriene synthesis therewith |
| US5081054A (en) * | 1989-04-03 | 1992-01-14 | Atmel Corporation | Fabrication process for programmable and erasable MOS memory device |
| US4960786A (en) * | 1989-04-24 | 1990-10-02 | Merrell Dow Pharmaceuticals Inc. | Excitatory amino acid antagonists |
| US5374615A (en) * | 1990-10-31 | 1994-12-20 | E. R. Squibb & Sons, Inc. | Indole- and benzimidazole-substituted imidazole and benzimidazole derivatives |
| US5189054A (en) * | 1990-11-02 | 1993-02-23 | Merrell Dow Pharmaceuticals Inc. | 3-amidoindolyl derivatives and pharmaceutical compositions thereof |
| US5294722A (en) * | 1992-04-16 | 1994-03-15 | E. R. Squibb & Sons, Inc. | Process for the preparation of imidazoles useful in angiotensin II antagonism |
| US5236916A (en) * | 1992-05-26 | 1993-08-17 | E. R. Squibb & Sons, Inc. | Oxadiazinone substituted indole and benzimidazole derivatives |
| TW229140B (cg-RX-API-DMAC7.html) * | 1992-06-05 | 1994-09-01 | Shell Internat Res Schappej B V | |
| US6075037A (en) * | 1994-06-09 | 2000-06-13 | Smithkline Beecham Corporation | Endothelin receptor antagonists |
| US6630496B1 (en) * | 1996-08-26 | 2003-10-07 | Genetics Institute Llc | Inhibitors of phospholipase enzymes |
| GB9716656D0 (en) * | 1997-08-07 | 1997-10-15 | Zeneca Ltd | Chemical compounds |
| GB9716657D0 (en) * | 1997-08-07 | 1997-10-15 | Zeneca Ltd | Chemical compounds |
| BR9814340B1 (pt) * | 1997-12-24 | 2010-07-13 | compostos derivados de indol, processo para a preparação dos mesmo e composição farmacêutica. | |
| GB9803228D0 (en) * | 1998-02-17 | 1998-04-08 | Zeneca Ltd | Chemical compounds |
| US6828344B1 (en) * | 1998-02-25 | 2004-12-07 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
| US6500853B1 (en) * | 1998-02-28 | 2002-12-31 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
| GB9902453D0 (en) * | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
| GB9902452D0 (en) * | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
| GB9902455D0 (en) * | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
| JP2001069477A (ja) * | 1999-08-31 | 2001-03-16 | Sony Corp | 番組提供システム及び番組提供方法 |
| US6353007B1 (en) * | 2000-07-13 | 2002-03-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents |
| IL154981A0 (en) * | 2000-10-10 | 2003-10-31 | Smithkline Beecham Corp | Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppay-y-binding agents |
-
2006
- 2006-01-19 US US11/795,573 patent/US20090048285A1/en not_active Abandoned
- 2006-01-19 WO PCT/GB2006/000168 patent/WO2006077401A1/en not_active Ceased
- 2006-01-19 JP JP2007551735A patent/JP2008527031A/ja not_active Withdrawn
- 2006-01-19 CA CA002594621A patent/CA2594621A1/en not_active Abandoned
- 2006-01-19 EP EP06700617A patent/EP1841766A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008527032A5 (cg-RX-API-DMAC7.html) | ||
| JP2008527027A5 (cg-RX-API-DMAC7.html) | ||
| JP2008527028A5 (cg-RX-API-DMAC7.html) | ||
| JP2008527030A5 (cg-RX-API-DMAC7.html) | ||
| CY2016017I2 (el) | Συνθεση για θεραπεια πνευμονικης υπερτασης | |
| WO2008118379A3 (en) | AMINO-5-[4-(DIFLUOROMETHOXY)PHENYL]-5-PHENYLIMIDAZOLONE COMPOUNDS FOR THE INHIBITION OF β-SECRETASE | |
| WO2009155001A3 (en) | Wnt protein signalling inhibitors | |
| WO2008011557A3 (en) | Heteroaryl inhibitors of rho kinase | |
| NO20091183L (no) | Derivater av 4-(N-azacykloalkyl)-anilider, fremgangsmåte for fremstilling av slike forbindelser, preparater omfattende slike forbindelser samt anvendelse av slike forbindelser for forhindring eller behandling av sykdom | |
| NO345119B1 (no) | Fremgangsmåte for å forhindre og/eller hemme dannelse av uorganiske fluoridavsetninger | |
| ATE516286T1 (de) | 5-(ä1,3,4üoxadiazol-2-yl)-1h-indazol und 5-(ä1,3, 4üthiadiazol-2-yl)-1h-indazol derivate als sgk- inhibitoren zur behandlung von diabetes | |
| WO2008048991A3 (en) | Organic compounds | |
| NO20091926L (no) | Anti-Notch3-agonist-antistoffer og deres anvendelse ved behandlingen av Notch3-relaterte sykdommer | |
| SMP200900058B (it) | Composti e composizioni come inibitori di proteinachinasi. | |
| WO2007120574A3 (en) | Diaryl substituted alkanes | |
| WO2007126957A3 (en) | New compounds | |
| SMAP201000118A (it) | Composto di ossimetilene arile e loro utilizzo. | |
| BRPI0808422A2 (pt) | Compostos orgânicos bicíclicos adequados para o tratamento de condições inflamatórias ou alérgicas | |
| ZA200802636B (en) | Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds as inhibitors of the beta-secretase (BACE) | |
| EA200900798A1 (ru) | Производные индол-4-илпиримидинил-2-иламина и их применение в качестве ингибиторов циклинзависимой киназы | |
| WO2009046842A3 (de) | Thialzolderivate zur behandlung von krebs | |
| WO2010033701A3 (en) | Inhibitors of sphingosine kinase 1 | |
| WO2007067781A3 (en) | 9-membered heterobicyclic compounds as inhibitors of protein kinases | |
| EA200800865A1 (ru) | Биарилзамещенные гетероциклические ингибиторы lta4h для лечения воспаления | |
| DK2445912T3 (da) | Ny forbindelse anvendelig til behandlingen af degenerative og inflammatoriske sygdomme |